Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2013126776) NANOSTRUCTURES FOR TREATING CANCERS AND OTHER CONDITIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2013/126776 International Application No.: PCT/US2013/027431
Publication Date: 29.08.2013 International Filing Date: 22.02.2013
IPC:
A61K 38/16 (2006.01) ,A61K 38/17 (2006.01) ,A61K 45/06 (2006.01) ,A61K 9/51 (2006.01) ,A61K 33/00 (2006.01) ,A61P 35/00 (2006.01) ,A61P 37/00 (2006.01) ,A61P 3/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
48
Preparations in capsules, e.g. of gelatin, of chocolate
50
Microcapsules
51
Nanocapsules
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33
Medicinal preparations containing inorganic active ingredients
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37
Drugs for immunological or allergic disorders
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
Applicants:
NORTHWESTERN UNIVERSITY [US/US]; 633 Clark Street Evanston, IL 60208, US
Inventors:
THAXTON, C., Shad; US
DAMIANO, Marina, G.; US
ZHANG, Heng; US
MCMAHON, Kaylin, M.; US
YANG, Shuo; US
GORDON, Leo, I.; US
SINGH, Amareshwar, T.k.; US
Agent:
LEE, Jessamine, N.; Wolf, Greenfield & Sacks, P.c. 600 Atlantic Avenue Boston, MA 02210-2206, US
Priority Data:
61/601,70622.02.2012US
Title (EN) NANOSTRUCTURES FOR TREATING CANCERS AND OTHER CONDITIONS
(FR) NANOSTRUCTURES PERMETTANT DE TRAITER DES CANCERS ET D'AUTRES PATHOLOGIES
Abstract:
(EN) Nanostructures, compositions and methods for treating cancers and other conditions are provided. In some cases, the nanostructures and/or compositions may be used to treat cancers or other diseases or conditions at least in part by controlling cholesterol metabolism in cells. The nanostructures and compositions may be used, for example, to control cholesterol influx and/or efflux in cells. In some cases, the nanostructures or compositions may be used to kill the cells. Examples of cancer cells that may be affected by the nanostructures and compositions described herein include those having scavenger receptor type B-I (SR-B1), B-cell lymphoma cells, non-Hodgkin's lymphoma cells, melanoma cells and/or others. In some embodiments, the nanostructures may be mimics of natural high-density lipoprotein (HDL).
(FR) La présente invention concerne des nanostructures, des compositions et des procédés permettant de traiter des cancers et d'autres pathologies. Dans certains cas, les nanostructures et/ou compositions peuvent être utilisés pour traiter des cancers ou d'autres maladies ou pathologies au moins en partie en contrôlant le métabolisme du cholestérol dans les cellules. Les nanostructures et compositions peuvent être utilisées, par exemple, pour réguler le flux entrant et/ou le flux sortant de cholestérol dans les cellules. Dans certains cas, les nanostructures ou les compositions peuvent être utilisées pour détruire les cellules. Des exemples de cellules cancéreuses qui peuvent être touchées par les nanostructures et les compositions décrites dans la présente invention comprennent celles présentant un récepteur scavenger de type B-I (SR-B1), des cellules de lymphome B, ces cellules de lymphome malin non hodgkinien, des cellules de mélanome et/ou d'autres. Dans certains modes de réalisation, les nanostructures peuvent imiter la lipoprotéine de haute densité naturelle (HDL).
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)